Home / Learn / Immunotherapy / View All IO Resources

View All IO Resources

Here is a comprehensive list of all of our immuno-oncology resources. Enter your search terms in the box below to filter your results.

Displaying results 21 - 40 of 120

Prev 1 2 3 4 5 6 Next
Survivorship care planning requires communication, care coordination, and education. Since immune-related adverse events are still being discovered, these discussions are even more imperative. 
Research nurse Joannne Riemer, RN, BSN,  started her position at Johns Hopkins Medical Institution in 2010. Within six months, she was working with checkpoint inhibitors. From her vantage point in clinical trials research, she discusses the many changes in IO clinical trials patient selection over the last eight years. 
August 23, 2018
Join the ACCC Immuno-Oncology Institute for a live webinar on the nuances of chimeric antigen (CAR) T-cell therapy, including appropriate patient selection, referral coordination, and communication among members of the multidisciplinary cancer care team. View On-Demand Replay Learning Objectives Understand the current and future applicability of CAR T-cell therapy Identify barriers an…
July 13, 2018
The ACCC Best Practices for Implementing Cancer Immunotherapy in the Community education program provides guidance and information on the practical issues surrounding immunotherapy delivery to all members of the multidisciplinary cancer team who care for cancer patients treated with this new class of agents. Expert faculty share learned experiences from this program in a one-hour webinar. Gain pra…
July 16, 2018
The Association of Community Cancer Centers Immuno-Oncology (IO) Visiting Experts Program has delivered customized workshops to cancer programs around the U.S. on effective practices for IO delivery and patient care coordination. Participate in the highly successful IO Visiting Experts workshop program in a virtual format.  The interactive discussion with our expert multidisciplinary present…
ACCC Immuno-Oncology Institute Executive Committee Chair Lee Schwartzberg, MD, FACP, highlights his top picks for compelling, potentially practice-changing immunotherapy abstracts presented during the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting. Dr. Schwartzberg is Chief, Division of Hematology Oncology; Professor of Medicine, University of Tennessee; and Executive D…
The Association of Community Cancer Centers recently spoke with Robyn Stacy-Humphries, MD, who was diagnosed with lymphoma in 2011, about her experience of treatment with CAR T-cell therapy in a clinical trial at the James Cancer Hospital at Ohio State University in Columbus, Ohio.
June 7, 2018
Part 3 of a 3-Part Series on Cancer Immunotherapies and Care Coordination Between the Multi-Specialty Team Members Survivorship care plans are a key piece of coordinated, patient-centered care delivery, and a requirement for Commission on Cancer accreditation. This one-hour webinar identifies challenges and solutions for immuno-oncology survivorship care planning; prepares your team for the nuance…
April 23, 2018
Part 2 of a 3-Part Series on Cancer Immunotherapies and Care Coordination Between the Multi-Specialty Team Members Learn why leading cancer programs are developing a toxicity team for patients on cancer immunotherapies, and how to build a toxicity team for your I-O program. Featured Speakers: Jarushka Naidoo, M.B.B.Ch. Assistant Professor of Oncology, Department of Oncology Sidney Kimmel Compreh…
February 1, 2017
View the archived webinar presentation given by Sanjiv S. Agarwala, MD, Chief of Medical Oncology & Hematology at St. Luke’s Cancer Center and Professor of Medicine at Temple University School of Medicine. Hear an overview of the history, current state, and future of therapy for patients with metastatic melanoma. The discussion will cover proper timing and choice of therapy for patients, …
October 12, 2017
View the archived ICLIO Webinar: Managing Immune-Related Adverse Events: Learning from Case Studies with expert presenter, Brianna Hoffner, MSN, NP, RN, Nurse Practitioner, University of Colorado Cancer Center. View On-Demand WebinarDownload Slides Early identification and management of immune-related adverse events (irAEs) is paramount. This webinar discusses the nuances of irAEs and illust…
November 29, 2017
View the archived webinar: The Microbiome in Cancer Immunotherapy with expert presenter, Sandip Patel, MD, Assistant Director, Cancer Immunotherapy Programs, Center for Personalized Cancer Therapy, UC San Diego Moores Cancer Center. Learn how the microbiome could potentially be used to predict and enhance response to I-O therapy and to recognize patients who could be at risk for developing im…
Our most viewed ACCC immuno-oncology resources in 2017 reveal ACCC members to be forward-looking with a strong multidisciplinary focus on process improvements to support and advance quality, patient-centered care.
Download Immuno-Oncology: Transforming the Delivery of Cancer Care in the Community for a summary of current progress in immunotherapies, challenges in I-O delivery, and solutions for optimizing patient care.
February 22, 2018
Part 1 of a 3-Part Series on Cancer Immunotherapies and Care Coordination Between the Multi-Specialty Team Members Featured Speakers: Jennie R. Crews, MD, MMM, FACP Medical Director Seattle Cancer Care Alliance Network Medical Director Seattle Cancer Care Alliance Research Integration Associate Clinical Professor University of Washington School of Medicine Seattle, WA Jeffrey P. Gregg, MD Senior D…
January 27, 2017
View the archived webinar presentation given by Jimmy Ruiz, MD, Assistant Professor of Medicine, Hematology and Oncology Assistant Director, Office of Cancer Health Equity Wake Forest Baptist Health, Comprehensive Cancer Center Medical Center. Learn how reflex testing can be used to inform treatment decisions in patients with advanced or metastatic non-small cell lung cancer (NSCLC)…
To learn about how immuno-oncology may affect survivorship care planning and to explore unique needs of cancer survivors who have been treated with I-O therapy, we spoke with Jennie Crews, MD, MMM, FACP, Medical Director of the Seattle Cancer Care Alliance Network and Research Integration.
To learn more about a unique approach to combining oncology and subspecialist expertise toward the goal of effective irAE management, the ACCC Institute for Clinical Immuno-Oncology spoke with medical oncologist Ryan Weight, DO, MS from the Sidney Kimmel Cancer Center (SKCC) of the Thomas Jefferson University, Philadelphia, Pennsylvania.

Displaying results 21 - 40 of 120

Prev 1 2 3 4 5 6 Next